Objectives A considerable portion of the adult population has received and/or is receiving
treatment with antiresorptive drugs (ARD s). It is thus relevant to assess possible side effects …

The present systematic review evaluates the safety of placing dental implants in patients
with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting …

Objective Bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ) is triggered by
inflammatory processes. Typical trigger factors are periodontal disease, denture pressure …

An increasing number of patients with medication-related osteonecrosis of the jaws
(MRONJ) has recently been reported. It is still being debated whether the presence or …

Purpose To identify the risk factors associated with relapse or treatment failure after surgery
for bisphosphonate-related osteonecrosis of the jaw (BRONJ) in patients with osteoporosis …

Purpose The management of maxillary medication‐related osteonecrosis of the jaw
(MRONJ) is challenging. Therefore, identifying the proper treatment is important. This study …

The purpose of the study was to evaluate the efficacy of conservative surgical treatment of
medication related osteonecrosis of the jaw (MRONJ) in patients affected by osteoporosis …

Objective To evaluate the 12-months incidence of MRONJ after tooth extractions and
possible related risk factors in patients with osteoporosis treated by means of oral …

A retrospective analysis was performed with the aim of understanding whether the risk
factors showed in the literature for medication-related osteonecrosis of the jaws (MRONJ) in …

Introduction Osteonecrosis of the jaw (ONJ) is a severe complication of antiresorptive
medication (AM) in the treatment of bone-affecting cancer-related conditions and …